Latest papers

BAFF, stimulatory DNA and IL-15 stimulates IgA(+) memory B cells and provides a novel approach for analysis of memory responses to mucosal vaccines.

The efficacy of influenza vaccination in a pediatric oncology population.

Field evaluation of an inactivated vaccine to control raccoon rabies in Ontario, Canada.

Possible adverse reactions in sheep after vaccination with inactivated BTV vaccines.

Influenza vaccination of children and infection rates in the community.

An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses.

Long-term immunity after two doses of inactivated hepatitis A vaccine, in Argentinean children.

A comparison of the antibody responses between specific pathogen-free and commercial layers immunized with an influenza vaccine prepared from inactivated non-pathogenic H5N1 virus by single shot.

Evaluation of the adjuvant activity of naloxone, an opioid receptor antagonist, in combination with heat-killed Listeria monocytogenes vaccine

Switching from OPV to IPV: are we behind the schedule in Latin America?

In vitro assessment of the allergenicity of a novel influenza vaccine produced in dog kidney cells in individuals with dog allergy

Japanese encephalitis vaccine. Useful for selected adult travellers.

[Long-term seroprotection against Japanese encephalitis using an inactivated vaccine (Jevax)].

IgA antibody response of swine to foot-and-mouth disease virus infection and vaccination.

Establishment of a biological reference preparation for hepatitis A vaccine (inactivated, non-adsorbed).

Field efficacy of an inactivated bivalent influenza vaccine in a multi-site swine production system during an outbreak of systemic porcine circovirus associated disease.

Safety and efficacy of an inactivated Carbopol-adjuvanted goose haemorrhagic polyomavirus vaccine for domestic geese.

Protection and differentiation of infected from vaccinated animals by an inactivated recombinant Newcastle disease virus/avian influenza H5 vaccine.

Protective efficacy of the H5 inactivated vaccine against different highly pathogenic H5N1 avian influenza viruses isolated in China and Vietnam.

Immunogenicity of poxvirus vector avian influenza vaccines in Muscovy and Pekin ducks.